| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.44 | $40.05 (0%) | 🛒 Add to cart |
| 120 | $0.37 | $53.40 $44.05 (18%) | 🛒 Add to cart |
| 180 | $0.30 | $80.10 $54.07 (32%) | 🛒 Add to cart |
| 360 | $0.22
Best per pill | $160.20 $79.10 (51%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.05 (0%) | 🛒 Add to cart |
| 90 | $0.55 | $64.58 $49.06 (24%) | 🛒 Add to cart |
| 120 | $0.46 | $86.11 $55.07 (36%) | 🛒 Add to cart |
| 180 | $0.38 | $129.16 $68.08 (47%) | 🛒 Add to cart |
| 270 | $0.32 | $193.74 $86.11 (56%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $258.32 $104.13 (60%) | 🛒 Add to cart |
| Product dosage: 750mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.97 | $59.07 (0%) | 🛒 Add to cart |
| 60 | $1.39 | $118.15 $83.10 (30%) | 🛒 Add to cart |
| 90 | $1.18 | $177.22 $106.13 (40%) | 🛒 Add to cart |
| 120 | $1.08 | $236.29 $130.16 (45%) | 🛒 Add to cart |
| 180 | $0.98 | $354.44 $177.22 (50%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $708.88 $317.39 (55%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Cipro: Potent Antibacterial Therapy for Resistant Infections - Evidence-Based Review
Ciprofloxacin, commonly referred to as Cipro, is a broad-spectrum fluoroquinolone antibiotic that has been a cornerstone in treating bacterial infections since its introduction in the late 1980s. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication, transcription, and repair. Available in oral tablets, intravenous formulations, and ophthalmic/otic solutions, Cipro is prescribed for a range of infections including urinary tract infections, respiratory tract infections, and gastrointestinal infections caused by susceptible bacteria.
ciprodex ophthalmic solution
Ciprodex ophthalmic solution combines ciprofloxacin 0.3% and dexamethasone 0.1% in a sterile suspension designed for ocular infections with significant inflammation. This antibiotic-steroid combination represents one of the most prescribed ophthalmic preparations in clinical practice, particularly for bacterial conjunctivitis and post-operative prophylaxis. What makes this formulation particularly effective is the synergy between the broad-spectrum fluoroquinolone and the potent corticosteroid - something we’ve observed repeatedly in clinical settings where inflammation complicates the infection picture.
Besivance Ophthalmic Solution: Effective Bacterial Conjunctivitis Treatment - Evidence-Based Review
Besivance ophthalmic solution is a sterile, topical antibiotic formulation specifically designed for ocular infections. It contains besifloxacin, a fluoroquinolone, in a concentration of 0.6% (6 mg/mL) as besifloxacin hydrochloride. The solution is preserved with benzalkonium chloride 0.01% and comes in a white, low-density polyethylene bottle with a controlled dropper tip. It’s a clear, slightly viscous liquid, which is a key feature of its formulation. 1. Introduction: What is Besivance Ophthalmic Solution?
Cefixime: Effective Bacterial Infection Treatment Across Multiple Indications - Evidence-Based Review
Cefixime is a third-generation oral cephalosporin antibiotic that’s been a workhorse in our infectious disease arsenal since the 1990s. What makes it particularly valuable in clinical practice is its broad-spectrum activity against Gram-negative bacteria while maintaining decent coverage against some Gram-positive organisms. Unlike earlier cephalosporins that required multiple daily dosing, cefixime’s extended half-life allows for once-daily administration, which significantly improves patient adherence - something we’ve all struggled with in outpatient settings.
Ciloxan Ophthalmic Solution: Effective Bacterial Conjunctivitis and Corneal Ulcer Treatment - Evidence-Based Review
Ciloxan ophthalmic solution contains ciprofloxacin, a broad-spectrum fluoroquinolone antibiotic, presented as a sterile, preserved, buffered solution. It’s indicated for treating corneal ulcers and bacterial conjunctivitis caused by susceptible strains. The formulation typically comes as a 0.3% solution in 5mL bottles with a controlled-drop tip for precise administration. What’s interesting about this preparation is the benzalkonium chloride preservative system - it’s both a blessing and a curse, really, since it maintains sterility but can cause issues with long-term use in sensitive patients.
Ciplox: Comprehensive Antibacterial Therapy for Complex Infections - Evidence-Based Review
Ciprofloxacin, marketed under brand names like Ciplox, is a broad-spectrum fluoroquinolone antibiotic that fundamentally changed how we approach bacterial infections when it first appeared. I remember our infectious disease department getting the first samples back in the late 80s - there was genuine excitement about having something that could tackle both Gram-positive and Gram-negative organisms with that kind of potency. What started as a hospital workhorse for serious infections gradually found its way to outpatient settings, though not without significant controversy along the way.
coumadin
Coumadin, known generically as warfarin, is one of those foundational medications in clinical practice that every internist and cardiologist develops a complicated relationship with over the years. It’s a vitamin K antagonist oral anticoagulant, and honestly, we’ve been using it since the 1950s. I remember as a resident being simultaneously terrified of its narrow therapeutic index and grateful for its proven efficacy in preventing thromboembolic events. The challenge has always been balancing its powerful anticoagulant effects with the very real risk of bleeding complications.
duricef
Cefadroxil, marketed under the brand name Duricef, is a first-generation cephalosporin antibiotic belonging to the beta-lactam class. It functions as a bactericidal agent by inhibiting bacterial cell wall synthesis, specifically targeting penicillin-binding proteins. Available in 500 mg and 1 g oral capsules and powder for suspension, its primary advantage lies in its prolonged half-life allowing for once or twice-daily dosing, which significantly improves patient compliance compared to other cephalosporins requiring more frequent administration.
Esbriet: Slowing Disease Progression in Idiopathic Pulmonary Fibrosis - Evidence-Based Review
Pirfenidone, marketed under the brand name Esbriet, represents a significant advancement in the management of idiopathic pulmonary fibrosis (IPF). This orally administered antifibrotic agent specifically targets the underlying pathological processes driving progressive lung scarring. Unlike traditional anti-inflammatory approaches that often prove inadequate for IPF, Esbriet works at the molecular level to interrupt the fibrotic cascade. The drug’s approval by regulatory agencies worldwide marked a paradigm shift from symptomatic management to disease-modifying therapy for this devastating condition.